CollPlant Biotech Regains Nasdaq Compliance

News related to:CollPlant Biotechnologies Ltd · 1 min read

REHOVOT, Israel, Sept. 22, 2026 /CourierPR/ -- CollPlant Biotechnologies Ltd. has regained compliance with Nasdaq's minimum bid price requirement, marking a significant milestone for the company. The firm had previously fallen out of compliance due to its stock price consistently trading below $1.00 per share for a period of 30 consecutive business days. However, CollPlant has now regained compliance, as its stock price has remained at or above $1.00 per share for the past ten consecutive business days.

The acquisition of LightSolver, a subsidiary focused on high-performance computing and photonics, has played a significant role in CollPlant's strategic expansion. LightSolver's subsidiary, LightSolver, is pioneering proprietary technology for the world's first Laser Processing Unit (LPU), which is expected to accelerate the development and market adoption of pure photonic computing.

CollPlant's subsidiary, CollPlant Ltd., continues to advance its proprietary rhCollagen platform and strategic industry collaborations, which are critical to the company's regenerative medicine and medical aesthetics sectors. The company remains committed to its diversified commercial and technological roadmap, which includes the development of the LPU and the continued advancement of its rhCollagen platform.

CollPlant Biotechnologies Ltd. is an innovative technology company operating at the intersection of deep-tech computing and advanced biotechnology. Through its subsidiary LightSolver, CollPlant is advancing the development of proprietary all-optical laser-based computing architectures designed to resolve the world's most demanding computational bottlenecks across artificial intelligence, aerospace, financial engineering, and high-performance computing. Concurrently, CollPlant remains a leader in regenerative medicine, pioneering plant-derived recombinant human collagen (rhCollagen) technologies for 3D bioprinting of tissues and organs and medical aesthetics.

The company's ability to maintain its Nasdaq listing is of paramount importance to its business collaborators and shareholders, reinforcing its commitment to transparent governance and a strong capital market positioning. The acquisition of LightSolver has further solidified CollPlant's position in the high-performance computing and photonics sectors, positioning the company for continued growth and success.

Start filing today

One press release free every week. No card required.

Create a free account